Matches in Nanopublications for { ?s ?p "[The identification of the Philadelphia chromosome and the subsequent discovery that it represents a translocation between the long arms of chromosomes 9 and 22 producing an aberrant tyrosine kinase, known as BCR-ABL1, has catalyzed our understanding and treatment of this hematologic malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP253224.RAZAvj4syXG6rQ32S7FyzUzA12W7zRHZUe0NDAhFHLwzo130_assertion description "[The identification of the Philadelphia chromosome and the subsequent discovery that it represents a translocation between the long arms of chromosomes 9 and 22 producing an aberrant tyrosine kinase, known as BCR-ABL1, has catalyzed our understanding and treatment of this hematologic malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253224.RAZAvj4syXG6rQ32S7FyzUzA12W7zRHZUe0NDAhFHLwzo130_provenance.
- assertion description "[The identification of the Philadelphia chromosome and the subsequent discovery that it represents a translocation between the long arms of chromosomes 9 and 22 producing an aberrant tyrosine kinase, known as BCR-ABL1, has catalyzed our understanding and treatment of this hematologic malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP219453.RAgMH7fdfPTrbRFIiXlmJpTTiQC2Fucq3dn1Ug1zPAECQ130_assertion description "[The identification of the Philadelphia chromosome and the subsequent discovery that it represents a translocation between the long arms of chromosomes 9 and 22 producing an aberrant tyrosine kinase, known as BCR-ABL1, has catalyzed our understanding and treatment of this hematologic malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219453.RAgMH7fdfPTrbRFIiXlmJpTTiQC2Fucq3dn1Ug1zPAECQ130_provenance.
- NP548794.RAdwIWS0Gfmt8gsJ2JJzCbnPMF6EKdbqBGi0FhedGZDXQ130_assertion description "[The identification of the Philadelphia chromosome and the subsequent discovery that it represents a translocation between the long arms of chromosomes 9 and 22 producing an aberrant tyrosine kinase, known as BCR-ABL1, has catalyzed our understanding and treatment of this hematologic malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548794.RAdwIWS0Gfmt8gsJ2JJzCbnPMF6EKdbqBGi0FhedGZDXQ130_provenance.